D114. Treatment of Congenital Muscular Torticollis: A Retrospective Cohort Study of Clinical and Surgical Outcomes

Abstract

PURPOSE: Congenital Muscular Torticollis (CMT) is an abnormal twisting of the head and neck due to the contraction of the sternocleidomastoid (SCM) muscle. Treatment options include physical therapy, botulinum toxin injections, and surgical SCM lengthening. In this study, we aim to present the efficacies of the various treatment options for CMT. METHODS: A retrospective cohort analysis was conducted on patients diagnosed with torticollis at a single center from 2016 to 2021. Inclusion criteria included patients who received medical treatment for torticollis with physical therapy (PT), Botox injections (Botox), or surgical SCM lengthening. Exclusion criteria included a diagnosis of synostosis or ocular torticollis. RESULTS: One hundred and thirty-one patients were identified for this study. Of the 131 patients identified, 109 patients met the inclusion criteria. 77 (70.6%) patients were successfully treated with PT, 18 patients with intramuscular Botox injection (16.5%), and 14 (12.9%) required surgical SCM lengthening. 56.2% of the patients recalcitrant to PT were treated with intramuscular Botox injection, and the remainder required SCM lengthening. CONCLUSION: This study describes the clinical outcomes of various treatment options for CMT. Botox and SCM lengthening procedures are safe adjunctive therapy options for patients with CMT recalcitrant to conservative therapy.